Optogenetic gene therapy holds great promise for healing blindness. Hulliger et al have developed a new promoter that effectively targets human ON bipolar cells. This is an important step towards clinical applications of optogenetic gene therapy for restoring vision.
Expert to Expert Interview with Prof. Botond Roska (IOB)
Watch Striatech’s Expert to Expert Interview with Prof. Botond Roska from the Institute of Molecular and Clinical Ophthalmology Basel (IOB).